References

1. Braga, D., Brammer, L., Champness, N. R, New trends in crystal engineering. CrystEngComm, 2005. 7: p. 1 - 19.
2. Desiraju, G.R., Hydrogen bridges incrystal engineering: Interactions without borders. Acc. Chem.Res, 2002. 35: p. 565-573.
3. Braga, D., Grepioni, F, Making crystals from crystals: a green route to crystal engineering and polymorphsim. Chem Commun, 2005: p. 3635-3645.
4. Kelly, P., Lawrence, S.E., Maguire, A.R, Asymmetric Synthesis of Aryl Benzyl Sulfoxides via Vanadium Catalysed Oxidation; a Combination of Enantioselective Sulfide Oxidation and Kinetic Resolution in Sulfoxide Oxidation. Eur. J. Org. Chem, 2006: p. 4500 - 4509.
5. Kelly, P., Lawrence, S.E., Maguire, A.R, Kinetic resolution in vanadium-catalysed sulfur oxidation as an efficient route to enantiopure aryl benzyl sulfoxide. Synlett, 2006: p. 1569-1573.
6. Kelleher, J.M., Lawrence, S.E., Moynihan, H.A, Effect of the steric demand and hydrogen bonding capacity of additives on the crystal polymorphism of sulfathiazole. CrystEngComm, 2006. 8: p. 327 - 332.
7. Kelleher, J.M., Lawrence, S.E., McAuliffe, M.T., Moynihan, H.A, Monomeric and polymeric derivatives of 5-aminoisophthalic acid as selective inhibitors of the beta-polymorph of L-glutamic acid. CrystEngComm, 2007. 9(1): p. 72 - 77.
8. Guiry, K.P., Kelleher, J.M., Lawrence, S.E., McAuliffe, M.T., Moynihan, H.A., Ryan, A.L, Crystal polymorphism of pharmaceuticals: probing crystal nucleation at the molecular level. J. Enz. Inhib. Med. Chem.
9. Staab, E., Addadi, L., Leiserowitz, L., Lahav, M, Control of polymorphism by 'tailor-made' polymeric crystallization auxiliaries. Preferential precipitation of a metastable polar form for second harmonic generation. Adv. Mater, 1990. 2: p. 40.
10. Davey, R.J., Blagden, N., Potts, G.D., Docherty, R, Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Conformational Mimicry. J. Am. Chem. Soc, 1997. 119: p. 1767.
11. Cashell, C., Corcoran, D., Hodnett, B.K, The Effect of Amino Acid Additives on the Crystallisation of  L-Glutamic Acid. Crystal Growth and Design, 2005. 5(2): p. 593-597.
12. Cashell C., Sutton, D., Corcoran D., Hodnett, B.K,  Inclusion of  the stable form of a polymorph within crystals of its metastable form. Crystal Growth and Design, 2003. 3: p. 869 - 873.
13. Huang, L.F., Tong, Impact of solid state properties on developability assessment of drug candidates. Adv. Drug Del. Rev., 2004. 56(3): p. 321 - 334.
14. Corrigan, O.I., Holohan, E.M, Amorphous spray-dried hydroflumethiazide-polyvinylpyrrolidone systems: physiochemical properties. J. Pharm. Pharmacol, 1984. 36(4): p. 217 - 221.
15. Taylor, L.S., Zografi, G, Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions Pharmaceutical Research, 1997. 14(12): p. 1691 - 1698.
16. Rehman, M., Shekunov, B.Y., York, P., Lechuga-Ballesteros, D., Miller, D.P., Tan, T, Colthorpe Optimisation of powders for pulmonary delivery using supercritical fluid technology. P. Eur. J. Pharm. Sci, 2004. 22(1): p. 1 - 17.
17. Newell, H.E., Buckton, G., Butler, D.A., Thielmann, F., Williams, D.R, The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation. Int. J. Pharm., 2001. 217(1 - 2): p. 45 - 56.
18. McDonald, B.F., Tajber, L., Corrigan, O.I., Healy, A.M, Nanoporous microparticles (NPMPs) of budesonide for pulmonary delivery. AAPS Journal, American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, USA, November 2006 American Association of Pharmaceutical Scientists, 2006. 8(S2): p. M1241.
19. Healy, A.M., Corrigan, O.I., Tajber, L., McDonald, B.A, PCT Application  No. PCT/IE07/000006. 2007.
20. Tajber. L., Corrigan, O., Healy, A.M, Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships. European Journal of Pharmaceutical Sciences, 2005. 24(5): p. 553 - 563.
21. Jacques, S., Pile, K., Barnes, P., Lai, X., Roberts, K.J., Williams, R.A, An In-Situ Synchrotron X-ray Diffraction Tomography Study of Crystallization and Preferred Crystal Orientation in a Stirred Reactor. Crystal Growth & Design, 2005. 5(2): p. 395 - 397.
22. O'Mahony, L., Curtin, T., Zemlyanov, D., Mihov, M., Hodnett, B.K, Surface species during the crystallization of VOHPO4*0.5H2O. J Catal 227 (2004) 270-281, 2004. 227: p. 270 - 281.
23. Loan, M., Loughlin, B., Haines, J., Croker, D., Fennell, M., Hodnett, B.K, In-situ time resolved synchrotron diffraction studies of high temperature Bayer digestion. Proceedings of the 7th International Alumina Quality Workshop, 2005, Perth., 2005.
24. O'Sullivan, B., Glennon, B, Application of in-situ FBRM and ATR-FTIR to the monitoring of the polymorphic Transformation of d-mannitol  Organic Process Research and Development, 2005. 9(6): p. 884 - 889.
25. Wei, H.Y., Zhou, W., Garside, J, Computational fluid dynamics modeling of the precipitation process in a semibatch crystallizer,. Ind. Eng. Chem. Res, 2001. 40 (23): p. 5255 - 5261.
26. Woo, X.Y., Tan, R.B.H., Chow, P.S, Braatz, R.D, Simulation of mixing effects in antisolvent crystallization using a coupled CFD-PDF-PBE approach. Crystal Growth & Design, 2006. 6(6): p. 1291-1303.
27. O'Grady, D., Barrett, M., Casey, E., Glennon, B, The Effect Of Mixing On The Metastable Zone Width and Nucleation Kinetics In the Anti-Solvent Crystallization of Benzoic Acid. Chem. Eng. Res. Des. Trans. IChemE part A, accepted for publication.
28. O'Grady, D., Glennon, B, Use of in-situ instrumentation to characterise anti-solvent addition crystallization. AIChE Annual Meeting, Cincinnati, USA, October, 2005, 2005.
29. O'Sullivan, B., Barrett, P., Hsiao, G., Carr, A., Glennon, B,  In-situ monitoring of polymorphic transitions. Org. Proc. Res. Dev, 2003. 7(6): p. 977 - 982
30. Barrett, P., Glennon, B, Chem. Eng. Res. Des., , Characterizing the Metastable Zone Width and Solubility Curve Using Lasentec FBRM and PVM. Trans. IChemE part A, 2002. 80: p. 799 - 805.
31. Politi, Y., Levi-Kalisman, Y., Raz, S., Wilt, F., Addadi, L.,Weiner, S., Sagi, I, Advanced Functional Materials. 2006. 16: p. 1289 - 1298.
32. Grant, D.J.W., Theory and origin of polymorphism. In: H.G. Brittain, Editor, Polymorphism in Pharmaceutical Solids Marcel Dekker, NY  1999. 95: p. 1 - 33.
33. Singhal, D., Curatolo, W Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Del. Rev., 2004. 56(3): p. 335 - 347.
34. Prescott, J.K., Barnum, R, On powder flowability. Pharm. Technol, A., 2000. 24(10): p. 60 - 84.
35. Hlinak, A.J., Kuriyan, K., Morris, K.R., Reklaitis, G.V., Basu, P.K Understanding Critical Material Properties for Solid Dosage Forms. J. Pharm. Innovation 2006. 1(1): p. 12 - 17.
36. Pratola, F., Simons, J. R., Jones, A.J, Novel Experimental Apparatus for the Measurement of Agglomerative Crystallization Forces. Trans IChemE, 2002. 80A: p. 441 - 448.
37. Brunsteiner, M., Jones, A.G., Pratola, F.,  Price, S.L., Simons, S.J.R, Towards a molecular understanding of crystal agglomeration: A Perspective. Crystal Growth and Design 2005. 5(1): p. 3 - 16.
38. Barrett, T.M., O'Grady, D., Glennon, B., Casey, E The Application of CFD to the Multi-Scale Characterization of Anti-Solvent Addition Crystallization. AIChE Annual Meeting, San Francisco, USA, 2006.
39. O' Grady, D., Barrett, M., Glennon, B, Scale-up of Anti-Solvent Crystallization Using in Situ Tools and Computational Fluid Dynamics,. AIChE Annual Meeting, San Francisco, USA., 2006.
40. Smoluchowski, M.Z., Versuch Einer Mathematischen Theorie Der Koagulationskinetik Kolloider Losunger. Zeitschrift fur  Physikalische Chemie, 1917. 92: p. 129 - 142.
41. Baldyga, J., Orciuch, W Closure method for precipitation in inhomogeneous turbulence. Proceeding of the 14th Internation Symposium on Industrial Crystallization, 1999.